206 related articles for article (PubMed ID: 18080699)
1. [The new serological markers of rheumatoid arthritis].
Tuchocka-Piotrowska A; Puszczewicz M
Pol Merkur Lekarski; 2007 Sep; 23(135):215-20. PubMed ID: 18080699
[TBL] [Abstract][Full Text] [Related]
2. Novel autoantibody markers for early and seronegative rheumatoid arthritis.
Somers K; Geusens P; Elewaut D; De Keyser F; Rummens JL; Coenen M; Blom M; Stinissen P; Somers V
J Autoimmun; 2011 Feb; 36(1):33-46. PubMed ID: 21071175
[TBL] [Abstract][Full Text] [Related]
3. [Anti-citrullinated peptide antibodies: novel markers for rheumatoid polyarthritis].
Yalaoui S
Arch Inst Pasteur Tunis; 2006; 83(1-4):13-7. PubMed ID: 19388592
[TBL] [Abstract][Full Text] [Related]
4. [Comparison and relevance of rheumatoid factors, antikeratin antibodies and anti-cyclic citrullinated peptides antibodies in rheumatoid arthritis].
Galati S; Beauvillain C; Renier G; Jeannin P; Masson C; Chevailler A
Ann Biol Clin (Paris); 2008; 66(2):157-64. PubMed ID: 18390426
[TBL] [Abstract][Full Text] [Related]
5. Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis.
Bang H; Egerer K; Gauliard A; Lüthke K; Rudolph PE; Fredenhagen G; Berg W; Feist E; Burmester GR
Arthritis Rheum; 2007 Aug; 56(8):2503-11. PubMed ID: 17665451
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies to citrullinated proteins in rheumatoid arthritis: clinical performance and biochemical aspects of an RA-specific marker.
Nijenhuis S; Zendman AJ; Vossenaar ER; Pruijn GJ; vanVenrooij WJ
Clin Chim Acta; 2004 Dec; 350(1-2):17-34. PubMed ID: 15530456
[TBL] [Abstract][Full Text] [Related]
7. [Anti-cyclic citrullinated peptide antibody as a serological marker for the diagnosis of rheumatoid arthritis].
Suzuki K
Nihon Rinsho; 2005 Jan; 63 Suppl 1():341-3. PubMed ID: 15799374
[No Abstract] [Full Text] [Related]
8. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis.
Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ
Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452
[TBL] [Abstract][Full Text] [Related]
9. [The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].
Aridoğan BC; Kaya S; Savaş S; Cetin ES; Akkuş S; Demirci M
Mikrobiyol Bul; 2008 Oct; 42(4):669-74. PubMed ID: 19149089
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies in rheumatoid arthritis: a review.
Mewar D; Wilson AG
Biomed Pharmacother; 2006 Dec; 60(10):648-55. PubMed ID: 17064873
[TBL] [Abstract][Full Text] [Related]
11. Proteomic: new advances in the diagnosis of rheumatoid arthritis.
Tampoia M; Brescia V; Fontana A; Maggiolini P; Zucano A; Pansini N
Clin Chim Acta; 2005 Jul; 357(2):219-25. PubMed ID: 15896730
[TBL] [Abstract][Full Text] [Related]
12. Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection.
Lim MK; Sheen DH; Lee YJ; Mun YR; Park M; Shim SC
J Rheumatol; 2009 Apr; 36(4):712-6. PubMed ID: 19286846
[TBL] [Abstract][Full Text] [Related]
13. Clinical value of second- and third-generation assays of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis.
Kitahara K; Takagi K; Kusunoki Y; Nishio S; Nozaki T; Inomata H; Takei M; Sawada S; Kawai S
Ann Rheum Dis; 2008 Jul; 67(7):1059-60. PubMed ID: 18556455
[No Abstract] [Full Text] [Related]
14. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
[TBL] [Abstract][Full Text] [Related]
15. Anti-cyclic citrullinated peptide in preclinical rheumatoid arthritis. Food for thought.
Ménard HA
J Rheumatol; 2009 Apr; 36(4):663-4. PubMed ID: 19342718
[No Abstract] [Full Text] [Related]
16. Anti-Sa sera from patients with rheumatoid arthritis contain at least 2 different subpopulations of anti-Sa antibodies.
Escalona M; López-Longo FJ; González CM; Monteagudo I; Rodríguez-Mahou M; Grau R; Carreño L
J Rheumatol; 2002 Oct; 29(10):2053-60. PubMed ID: 12375311
[TBL] [Abstract][Full Text] [Related]
17. IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin.
Chapuy-Regaud S; Nogueira L; Clavel C; Sebbag M; Vincent C; Serre G
Clin Exp Immunol; 2005 Mar; 139(3):542-50. PubMed ID: 15730401
[TBL] [Abstract][Full Text] [Related]
18. Optimization of high-throughput autoantibody profiling for the discovery of novel antigenic targets in rheumatoid arthritis.
Somers K; Stinissen P; Somers V
Ann N Y Acad Sci; 2009 Sep; 1173():92-102. PubMed ID: 19758137
[TBL] [Abstract][Full Text] [Related]
19. Antibodies against mutated citrullinated vimentin are a better predictor of disease activity at 24 months in early rheumatoid arthritis than antibodies against cyclic citrullinated peptides.
Innala L; Kokkonen H; Eriksson C; Jidell E; Berglin E; Dahlqvst SR
J Rheumatol; 2008 Jun; 35(6):1002-8. PubMed ID: 18398946
[TBL] [Abstract][Full Text] [Related]
20. Mutated citrullinated vimentin antibodies in rheumatoid arthritis.
Kuna AT
Clin Chim Acta; 2012 Jan; 413(1-2):66-73. PubMed ID: 22037509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
